A detailed history of Forsta Ap Fonden transactions in Moderna, Inc. stock. As of the latest transaction made, Forsta Ap Fonden holds 68,900 shares of MRNA stock, worth $2.54 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
68,900
Previous 60,500 13.88%
Holding current value
$2.54 Million
Previous $7.18 Million 35.91%
% of portfolio
0.04%
Previous 0.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$63.64 - $125.14 $534,576 - $1.05 Million
8,400 Added 13.88%
68,900 $4.6 Million
Q2 2024

Aug 08, 2024

SELL
$101.21 - $166.61 $617,381 - $1.02 Million
-6,100 Reduced 9.16%
60,500 $7.18 Million
Q1 2024

May 07, 2024

BUY
$85.37 - $115.44 $597,590 - $808,080
7,000 Added 11.74%
66,600 $7.1 Million
Q4 2023

Feb 06, 2024

SELL
$69.51 - $104.43 $215,481 - $323,733
-3,100 Reduced 4.94%
59,600 $5.93 Million
Q3 2023

Oct 25, 2023

BUY
$96.41 - $126.61 $28,923 - $37,983
300 Added 0.48%
62,700 $6.48 Million
Q2 2023

Aug 03, 2023

BUY
$118.5 - $160.53 $35,550 - $48,159
300 Added 0.48%
62,400 $7.58 Million
Q1 2023

Apr 21, 2023

SELL
$135.66 - $197.02 $7.33 Million - $10.6 Million
-54,000 Reduced 46.51%
62,100 $9.54 Million
Q4 2022

Feb 02, 2023

BUY
$118.38 - $210.04 $2.91 Million - $5.17 Million
24,600 Added 26.89%
116,100 $20.9 Million
Q3 2022

Oct 17, 2022

BUY
$118.07 - $194.18 $3.59 Million - $5.9 Million
30,400 Added 49.75%
91,500 $10.8 Million
Q2 2022

Aug 11, 2022

SELL
$117.13 - $176.59 $2.55 Million - $3.85 Million
-21,800 Reduced 26.3%
61,100 $8.73 Million
Q1 2022

May 09, 2022

BUY
$126.46 - $235.05 $101,168 - $188,040
800 Added 0.97%
82,900 $14.3 Million
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $1.15 Million - $1.88 Million
5,100 Added 6.62%
82,100 $20.9 Million
Q3 2021

Nov 10, 2021

BUY
$221.9 - $484.47 $155,330 - $339,129
700 Added 0.92%
77,000 $29.6 Million
Q2 2021

Aug 12, 2021

BUY
$129.91 - $234.98 $2.77 Million - $5.01 Million
21,300 Added 38.73%
76,300 $17.9 Million
Q1 2021

May 11, 2021

BUY
$109.18 - $185.98 $600,490 - $1.02 Million
5,500 Added 11.11%
55,000 $7.2 Million
Q4 2020

Feb 09, 2021

SELL
$65.74 - $169.86 $322,126 - $832,314
-4,900 Reduced 9.01%
49,500 $5.17 Million
Q3 2020

Feb 19, 2021

BUY
$54.34 - $94.85 $2.96 Million - $5.16 Million
54,400 New
54,400 $3.85 Million
Q3 2020

Oct 22, 2020

SELL
$54.34 - $94.85 $2.03 Million - $3.54 Million
-37,300 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$29.67 - $80.0 $1.11 Million - $2.98 Million
37,300 New
37,300 $2.4 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Forsta Ap Fonden Portfolio

Follow Forsta Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.